Exact Mass: 501.27332440000004
Exact Mass Matches: 501.27332440000004
Found 500 metabolites which its exact mass value is equals to given mass value 501.27332440000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fexofenadine
C32H39NO4 (501.28789340000003)
Fexofenadine is an antihistamine drug used in the treatment of hayfever and similar allergy symptoms. It was developed as a successor of and alternative to terfenadine, an antihistamine with potentially fatal contraindications. Fexofenadine, like other second-generation antihistamines, does not readily enter the brain from the blood, and so causes less drowsiness than first generation histamine receptor antagonists; Fexofenadine hydrochloride (brand names include Allegra and Telfast) is an antihistamine drug used in the treatment of hayfever and similar allergy symptoms. It was developed as a successor of and alternative to terfenadine, an antihistamine with potentially fatal contraindications. Fexofenadine, like other second generation antihistamines, does not readily enter the brain from the blood, and so causes less drowsiness than first-generation histamine-receptor antagonists. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Fexofenadine (MDL-16455) is an orally active and nonsedative H1 receptor antagonist. Fexofenadine can be used in allergic rhinitis and chronic idiopathic urticarial research[1][2][3].
Avasimibe
C29H43NO4S (501.2912638000001)
D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent Avasimibe (CI-1011; PD-148515) is an orally active acyl coenzyme A-cholesterol acyltransferase (ACAT; also called SOAT)) inhibitor with IC50s of 24 and 9.2 μM for ACAT1 and ACAT2, respectively[1]. Avasimibe can be used for the research of prostate cancer[2].
LysoPE(0:0/20:4(5Z,8Z,11Z,14Z))
C25H44NO7P (501.28552440000004)
LysoPE(0:0/20:4(5Z,8Z,11Z,14Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/20:4(5Z,8Z,11Z,14Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(0:0/20:4(8Z,11Z,14Z,17Z))
C25H44NO7P (501.28552440000004)
LysoPE(0:0/20:4(8Z,11Z,14Z,17Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/20:4(8Z,11Z,14Z,17Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(20:4/0:0)
C25H44NO7P (501.28552440000004)
LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(20:4(8Z,11Z,14Z,17Z)/0:0)
C25H44NO7P (501.28552440000004)
LysoPE(20:4(8Z,11Z,14Z,17Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(20:4(8Z,11Z,14Z,17Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
Avasimibe
C29H43NO4S (501.2912638000001)
Glycerophospho-N-Arachidonoyl Ethanolamine
C25H44NO7P (501.28552440000004)
fexofenadine
C32H39NO4 (501.28789340000003)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist CONFIDENCE standard compound; EAWAG_UCHEM_ID 3019 D018926 - Anti-Allergic Agents Fexofenadine (MDL-16455) is an orally active and nonsedative H1 receptor antagonist. Fexofenadine can be used in allergic rhinitis and chronic idiopathic urticarial research[1][2][3].
(2S)-3-Methyl-2-[(2R,2R,6S,7R,8aS)-4,6,7-trihydroxy-2,5,5,8a-tetramethyl-6-oxo-3,4,4a,5,6,6,7,8,8,8a-decahydro-2H-spiro[furo[2,3-E]isoindole-2,1-naphthalen]-7(3H)-yl]butanoic acid
Phosphatidylethanolamine lyso 20:4
C25H44NO7P (501.28552440000004)
c(Gly-Pro-Tyr-Leu-Ala)|cyclo(Ala-Gly-Pro-Tyr-Leu-)|cyclo(ProTyrLeuAlaGly)|pseudostellarin|pseudostellarin A
C25H35N5O6 (501.25872100000004)
His Ala Phe Lys
C24H35N7O5 (501.26995400000004)
Val Arg Ile Asp
Val Asp Ile Arg
Ala Phe His Lys
C24H35N7O5 (501.26995400000004)
C28H39NO7_Spiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalene]-7(3H)-acetic acid, 3,4,4a,5,6,6,7,8,8,8a-decahydro-4,6,7-trihydroxy-2,5,5,8a-tetramethyl-alpha-(1-methylethyl)-6-oxo-, (alphaS,2R,2R,6S,7R,8aS)
(2S)-2-[(2R,3S,7R,8R,8aS)-2,3,4-trihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]-3-methylbutanoic acid
2-((3R)-3-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanamido)ethane-1-sulfonic acid
C25H43NO7S (501.27600880000006)
Ala Phe Lys His
C24H35N7O5 (501.26995400000004)
Ala His Phe Lys
C24H35N7O5 (501.26995400000004)
Ala His Lys Phe
C24H35N7O5 (501.26995400000004)
Ala Ile Ile Trp
Ala Ile Leu Trp
Ala Ile Trp Ile
Ala Ile Trp Leu
Ala Lys Phe His
C24H35N7O5 (501.26995400000004)
Ala Lys His Phe
C24H35N7O5 (501.26995400000004)
Ala Gln Gln Arg
Ala Gln Arg Gln
Ala Arg Gln Gln
Asp Ile Arg Val
Asp Ile Val Arg
Asp Leu Arg Val
Asp Leu Val Arg
Asp Arg Ile Val
Asp Arg Leu Val
Asp Arg Val Ile
Asp Arg Val Leu
Asp Val Ile Arg
Asp Val Leu Arg
Asp Val Arg Ile
Asp Val Arg Leu
Glu Ile Ile Gln
Glu Ile Leu Gln
Glu Ile Gln Ile
Glu Ile Gln Leu
Glu Leu Ile Gln
Glu Leu Leu Gln
Glu Leu Gln Ile
Glu Leu Gln Leu
Glu Pro Arg Thr
Glu Pro Thr Arg
Glu Gln Ile Ile
Glu Gln Ile Leu
Glu Gln Leu Ile
Glu Gln Leu Leu
Glu Arg Pro Thr
Glu Arg Thr Pro
Glu Arg Val Val
Glu Thr Pro Arg
Glu Thr Arg Pro
Glu Val Arg Val
Glu Val Val Arg
Phe Ala His Lys
C24H35N7O5 (501.26995400000004)
Phe Ala Lys His
C24H35N7O5 (501.26995400000004)
Phe His Ala Lys
C24H35N7O5 (501.26995400000004)
Phe His Lys Ala
C24H35N7O5 (501.26995400000004)
Phe Lys Ala His
C24H35N7O5 (501.26995400000004)
Phe Lys His Ala
C24H35N7O5 (501.26995400000004)
Gly Asn Arg Arg
Gly Arg Asn Arg
Gly Arg Arg Asn
His Ala Lys Phe
C24H35N7O5 (501.26995400000004)
His Phe Ala Lys
C24H35N7O5 (501.26995400000004)
His Phe Lys Ala
C24H35N7O5 (501.26995400000004)
His Lys Ala Phe
C24H35N7O5 (501.26995400000004)
His Lys Phe Ala
C24H35N7O5 (501.26995400000004)
Ile Asp Arg Val
Ile Asp Val Arg
Ile Glu Ile Gln
Ile Glu Leu Gln
Ile Glu Gln Ile
Ile Glu Gln Leu
Ile Ile Glu Gln
Ile Ile Gln Glu
Ile Lys Asn Gln
Ile Lys Gln Asn
Ile Leu Glu Gln
Ile Leu Gln Glu
Ile Asn Lys Gln
Ile Asn Gln Lys
Ile Asn Gln Gln
Ile Pro Ser Trp
C25H35N5O6 (501.25872100000004)
Ile Pro Trp Ser
C25H35N5O6 (501.25872100000004)
Ile Gln Glu Ile
Ile Gln Glu Leu
Ile Gln Ile Glu
Ile Gln Lys Asn
Ile Gln Leu Glu
Ile Gln Asn Lys
Ile Gln Asn Gln
Ile Gln Gln Asn
Ile Arg Asp Val
Ile Arg Val Asp
Ile Ser Pro Trp
C25H35N5O6 (501.25872100000004)
Ile Ser Trp Pro
C25H35N5O6 (501.25872100000004)
Ile Val Asp Arg
Ile Val Arg Asp
Ile Trp Pro Ser
C25H35N5O6 (501.25872100000004)
Ile Trp Ser Pro
C25H35N5O6 (501.25872100000004)
Lys Ala Phe His
C24H35N7O5 (501.26995400000004)
Lys Ala His Phe
C24H35N7O5 (501.26995400000004)
Lys Phe Ala His
C24H35N7O5 (501.26995400000004)
Lys Phe His Ala
C24H35N7O5 (501.26995400000004)
Lys His Ala Phe
C24H35N7O5 (501.26995400000004)
Lys His Phe Ala
C24H35N7O5 (501.26995400000004)
Lys Ile Asn Gln
Lys Ile Gln Asn
Lys Leu Asn Gln
Lys Leu Gln Asn
Lys Asn Ile Gln
Lys Asn Leu Gln
Lys Asn Gln Ile
Lys Asn Gln Leu
Lys Gln Ile Asn
Lys Gln Leu Asn
Lys Gln Asn Ile
Lys Gln Asn Leu
Lys Gln Gln Val
Lys Gln Val Gln
Lys Val Gln Gln
Leu Asp Arg Val
Leu Asp Val Arg
Leu Glu Ile Gln
Leu Glu Leu Gln
Leu Glu Gln Ile
Leu Glu Gln Leu
Leu Ile Glu Gln
Leu Ile Gln Glu
Leu Lys Asn Gln
Leu Lys Gln Asn
Leu Leu Glu Gln
Leu Leu Gln Glu
Leu Asn Lys Gln
Leu Asn Gln Lys
Leu Asn Gln Gln
Leu Pro Ser Trp
C25H35N5O6 (501.25872100000004)
Leu Pro Trp Ser
C25H35N5O6 (501.25872100000004)
Leu Gln Glu Ile
Leu Gln Glu Leu
Leu Gln Ile Glu
Leu Gln Lys Asn
Leu Gln Leu Glu
Leu Gln Asn Lys
Leu Gln Asn Gln
Leu Gln Gln Asn
Leu Arg Asp Val
Leu Arg Val Asp
Leu Ser Pro Trp
C25H35N5O6 (501.25872100000004)
Leu Ser Trp Pro
C25H35N5O6 (501.25872100000004)
Leu Val Asp Arg
Leu Val Arg Asp
Leu Trp Pro Ser
C25H35N5O6 (501.25872100000004)
Leu Trp Ser Pro
C25H35N5O6 (501.25872100000004)
Met Pro Arg Val
C21H39N7O5S (501.27332440000004)
Met Pro Val Arg
C21H39N7O5S (501.27332440000004)
Met Arg Pro Val
C21H39N7O5S (501.27332440000004)
Met Arg Val Pro
C21H39N7O5S (501.27332440000004)
Met Val Pro Arg
C21H39N7O5S (501.27332440000004)
Met Val Arg Pro
C21H39N7O5S (501.27332440000004)
Asn Gly Arg Arg
Asn Ile Lys Gln
Asn Ile Gln Lys
Asn Ile Gln Gln
Asn Lys Ile Gln
Asn Lys Leu Gln
Asn Lys Gln Ile
Asn Lys Gln Leu
Asn Leu Lys Gln
Asn Leu Gln Lys
Asn Leu Gln Gln
Asn Asn Arg Val
Asn Asn Val Arg
Asn Gln Ile Lys
Asn Gln Ile Gln
Asn Gln Lys Ile
Asn Gln Lys Leu
Asn Gln Leu Lys
Asn Gln Leu Gln
Asn Gln Gln Ile
Asn Gln Gln Leu
Asn Arg Gly Arg
Asn Arg Asn Val
Asn Arg Arg Gly
Asn Arg Val Asn
Asn Val Asn Arg
Asn Val Arg Asn
Pro Glu Arg Thr
Pro Glu Thr Arg
Pro Ile Ser Trp
C25H35N5O6 (501.25872100000004)
Pro Ile Trp Ser
C25H35N5O6 (501.25872100000004)
Pro Leu Ser Trp
C25H35N5O6 (501.25872100000004)
Pro Leu Trp Ser
C25H35N5O6 (501.25872100000004)
Pro Met Arg Val
C21H39N7O5S (501.27332440000004)
Pro Met Val Arg
C21H39N7O5S (501.27332440000004)
Pro Arg Glu Thr
Pro Arg Met Val
C21H39N7O5S (501.27332440000004)
Pro Arg Thr Glu
Pro Arg Val Met
C21H39N7O5S (501.27332440000004)
Pro Ser Ile Trp
C25H35N5O6 (501.25872100000004)
Pro Ser Leu Trp
C25H35N5O6 (501.25872100000004)
Pro Ser Trp Ile
C25H35N5O6 (501.25872100000004)
Pro Ser Trp Leu
C25H35N5O6 (501.25872100000004)
Pro Thr Glu Arg
Pro Thr Arg Glu
Pro Thr Val Trp
C25H35N5O6 (501.25872100000004)
Pro Thr Trp Val
C25H35N5O6 (501.25872100000004)
Pro Val Met Arg
C21H39N7O5S (501.27332440000004)
Pro Val Arg Met
C21H39N7O5S (501.27332440000004)
Pro Val Thr Trp
C25H35N5O6 (501.25872100000004)
Pro Val Trp Thr
C25H35N5O6 (501.25872100000004)
Pro Trp Ile Ser
C25H35N5O6 (501.25872100000004)
Pro Trp Leu Ser
C25H35N5O6 (501.25872100000004)
Pro Trp Ser Ile
C25H35N5O6 (501.25872100000004)
Pro Trp Ser Leu
C25H35N5O6 (501.25872100000004)
Pro Trp Thr Val
C25H35N5O6 (501.25872100000004)
Pro Trp Val Thr
C25H35N5O6 (501.25872100000004)
Gln Ala Gln Arg
Gln Ala Arg Gln
Gln Glu Ile Ile
Gln Glu Ile Leu
Gln Glu Leu Ile
Gln Glu Leu Leu
Gln Ile Glu Ile
Gln Ile Glu Leu
Gln Ile Ile Glu
Gln Ile Lys Asn
Gln Ile Leu Glu
Gln Ile Asn Lys
Gln Ile Asn Gln
Gln Ile Gln Asn
Gln Lys Ile Asn
Gln Lys Leu Asn
Gln Lys Asn Ile
Gln Lys Asn Leu
Gln Lys Gln Val
Gln Lys Val Gln
Gln Leu Glu Ile
Gln Leu Glu Leu
Gln Leu Ile Glu
Gln Leu Lys Asn
Gln Leu Leu Glu
Gln Leu Asn Lys
Gln Leu Asn Gln
Gln Leu Gln Asn
Gln Asn Ile Lys
Gln Asn Ile Gln
Gln Asn Lys Ile
Gln Asn Lys Leu
Gln Asn Leu Lys
Gln Asn Leu Gln
Gln Asn Gln Ile
Gln Asn Gln Leu
Gln Gln Ala Arg
Gln Gln Ile Asn
Gln Gln Lys Val
Gln Gln Leu Asn
Gln Gln Asn Ile
Gln Gln Asn Leu
Gln Gln Gln Val
Gln Gln Arg Ala
Gln Gln Val Lys
Gln Gln Val Gln
Gln Arg Ala Gln
Gln Arg Gln Ala
Gln Val Lys Gln
Gln Val Gln Lys
Gln Val Gln Gln
Arg Ala Gln Gln
Arg Asp Ile Val
Arg Asp Leu Val
Arg Asp Val Ile
Arg Asp Val Leu
Arg Glu Pro Thr
Arg Glu Thr Pro
Arg Glu Val Val
Arg Gly Asn Arg
Arg Gly Arg Asn
Arg Ile Asp Val
Arg Ile Val Asp
Arg Leu Asp Val
Arg Leu Val Asp
Arg Met Pro Val
C21H39N7O5S (501.27332440000004)
Arg Met Val Pro
C21H39N7O5S (501.27332440000004)
Arg Asn Gly Arg
Arg Asn Asn Val
Arg Asn Arg Gly
Arg Asn Val Asn
Arg Pro Glu Thr
Arg Pro Met Val
C21H39N7O5S (501.27332440000004)
Arg Pro Thr Glu
Arg Pro Val Met
C21H39N7O5S (501.27332440000004)
Arg Gln Ala Gln
Arg Gln Gln Ala
Arg Arg Gly Asn
Arg Arg Asn Gly
Arg Thr Glu Pro
Arg Thr Pro Glu
Arg Val Asp Ile
Arg Val Asp Leu
Arg Val Glu Val
Arg Val Ile Asp
Arg Val Leu Asp
Arg Val Met Pro
C21H39N7O5S (501.27332440000004)
Arg Val Asn Asn
Arg Val Pro Met
C21H39N7O5S (501.27332440000004)
Arg Val Val Glu
Ser Ile Pro Trp
C25H35N5O6 (501.25872100000004)
Ser Ile Trp Pro
C25H35N5O6 (501.25872100000004)
Ser Leu Pro Trp
C25H35N5O6 (501.25872100000004)
Ser Leu Trp Pro
C25H35N5O6 (501.25872100000004)
Ser Pro Ile Trp
C25H35N5O6 (501.25872100000004)
Ser Pro Leu Trp
C25H35N5O6 (501.25872100000004)
Ser Pro Trp Ile
C25H35N5O6 (501.25872100000004)
Ser Pro Trp Leu
C25H35N5O6 (501.25872100000004)
Ser Trp Ile Pro
C25H35N5O6 (501.25872100000004)
Ser Trp Leu Pro
C25H35N5O6 (501.25872100000004)
Ser Trp Pro Ile
C25H35N5O6 (501.25872100000004)
Ser Trp Pro Leu
C25H35N5O6 (501.25872100000004)
Thr Glu Pro Arg
Thr Glu Arg Pro
Thr Pro Glu Arg
Thr Pro Arg Glu
Thr Pro Val Trp
C25H35N5O6 (501.25872100000004)
Thr Pro Trp Val
C25H35N5O6 (501.25872100000004)
Thr Arg Glu Pro
Thr Arg Pro Glu
Thr Val Pro Trp
C25H35N5O6 (501.25872100000004)
Thr Val Trp Pro
C25H35N5O6 (501.25872100000004)
Thr Trp Pro Val
C25H35N5O6 (501.25872100000004)
Thr Trp Val Pro
C25H35N5O6 (501.25872100000004)
Val Asp Leu Arg
Val Asp Arg Ile
Val Asp Arg Leu
Val Glu Arg Val
Val Glu Val Arg
Val Ile Asp Arg
Val Ile Arg Asp
Val Lys Gln Gln
Val Leu Asp Arg
Val Leu Arg Asp
Val Met Pro Arg
C21H39N7O5S (501.27332440000004)
Val Met Arg Pro
C21H39N7O5S (501.27332440000004)
Val Asn Asn Arg
Val Asn Arg Asn
Val Pro Met Arg
C21H39N7O5S (501.27332440000004)
Val Pro Arg Met
C21H39N7O5S (501.27332440000004)
Val Pro Thr Trp
C25H35N5O6 (501.25872100000004)
Val Pro Trp Thr
C25H35N5O6 (501.25872100000004)
Val Gln Lys Gln
Val Gln Gln Lys
Val Gln Gln Gln
Val Arg Asp Ile
Val Arg Asp Leu
Val Arg Glu Val
Val Arg Leu Asp
Val Arg Met Pro
C21H39N7O5S (501.27332440000004)
Val Arg Asn Asn
Val Arg Pro Met
C21H39N7O5S (501.27332440000004)
Val Arg Val Glu
Val Thr Pro Trp
C25H35N5O6 (501.25872100000004)
Val Thr Trp Pro
C25H35N5O6 (501.25872100000004)
Val Val Glu Arg
Val Val Arg Glu
Val Trp Pro Thr
C25H35N5O6 (501.25872100000004)
Val Trp Thr Pro
C25H35N5O6 (501.25872100000004)
Trp Ile Pro Ser
C25H35N5O6 (501.25872100000004)
Trp Ile Ser Pro
C25H35N5O6 (501.25872100000004)
Trp Leu Pro Ser
C25H35N5O6 (501.25872100000004)
Trp Leu Ser Pro
C25H35N5O6 (501.25872100000004)
Trp Pro Ile Ser
C25H35N5O6 (501.25872100000004)
Trp Pro Leu Ser
C25H35N5O6 (501.25872100000004)
Trp Pro Ser Ile
C25H35N5O6 (501.25872100000004)
Trp Pro Ser Leu
C25H35N5O6 (501.25872100000004)
Trp Pro Thr Val
C25H35N5O6 (501.25872100000004)
Trp Pro Val Thr
C25H35N5O6 (501.25872100000004)
Trp Ser Ile Pro
C25H35N5O6 (501.25872100000004)
Trp Ser Leu Pro
C25H35N5O6 (501.25872100000004)
Trp Ser Pro Ile
C25H35N5O6 (501.25872100000004)
Trp Ser Pro Leu
C25H35N5O6 (501.25872100000004)
Trp Thr Pro Val
C25H35N5O6 (501.25872100000004)
Trp Thr Val Pro
C25H35N5O6 (501.25872100000004)
Trp Val Pro Thr
C25H35N5O6 (501.25872100000004)
Trp Val Thr Pro
C25H35N5O6 (501.25872100000004)
Glycerophospho-N-Arachidonoyl Ethanolamine
C25H44NO7P (501.28552440000004)
PE(20:4/0:0)
C25H44NO7P (501.28552440000004)
LPE(20:4)
C25H44NO7P (501.28552440000004)
1-Eicsoate
C25H44NO7P (501.28552440000004)
LPE 20:4
C25H44NO7P (501.28552440000004)
(2E,12R)-12-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]-2-tridecenoic acid
fexofenadine
C32H39NO4 (501.28789340000003)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Fexofenadine is an antihistamine drug used in the treatment of hayfever and similar allergy symptoms. It was developed as a successor of and alternative to terfenadine, an antihistamine with potentially fatal contraindications. Fexofenadine, like other second-generation antihistamines, does not readily enter the brain from the blood, and so causes less drowsiness than first generation histamine receptor antagonists; Fexofenadine hydrochloride (brand names include Allegra and Telfast) is an antihistamine drug used in the treatment of hayfever and similar allergy symptoms. It was developed as a successor of and alternative to terfenadine, an antihistamine with potentially fatal contraindications. Fexofenadine, like other second generation antihistamines, does not readily enter the brain from the blood, and so causes less drowsiness than first-generation histamine-receptor antagonists. [HMDB] Fexofenadine (MDL-16455) is an orally active and nonsedative H1 receptor antagonist. Fexofenadine can be used in allergic rhinitis and chronic idiopathic urticarial research[1][2][3].
N-arachidonoyl-sn-glycero-3-phosphoethanolamine
C25H44NO7P (501.28552440000004)
(2S)-N-[(S)-[(2S,6R)-6-[(2S)-2,3-dimethoxypropyl]-5,5-dimethyl-4-oxooxan-2-yl]-methoxymethyl]-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetamide
C25H43NO9 (501.29376680000007)
2,3-dihydroxypropyl 2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]ethyl hydrogen phosphate
C25H44NO7P (501.28552440000004)
2-azaniumylethyl (2R)-3-hydroxy-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propyl phosphate
C25H44NO7P (501.28552440000004)
2-((3R)-3-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanamido)ethane-1-sulfonic acid
C25H43NO7S (501.27600880000006)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzamide
C30H35N3O4 (501.26274300000006)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzamide
C30H35N3O4 (501.26274300000006)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzamide
C30H35N3O4 (501.26274300000006)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-phenylbenzamide
C30H35N3O4 (501.26274300000006)
N-[(5S,6S,9R)-8-[(3-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5R,6R,9S)-8-[(3-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-piperidin-1-ylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5S,6R,9R)-8-[(2-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5R,6S,9S)-8-[(2-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-phenylurea
C30H35N3O4 (501.26274300000006)
1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-phenylurea
C30H35N3O4 (501.26274300000006)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(5R,6R,9R)-8-[(3-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5R,6S,9R)-8-[(3-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6S,9S)-8-[(3-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6R,9R)-8-[(3-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(5R,6R,9R)-8-[(2-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5R,6R,9S)-8-[(2-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6S,9R)-8-[(2-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
N-[(5S,6R,9S)-8-[(2-fluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide
1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-phenylurea
C30H35N3O4 (501.26274300000006)
1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-phenylurea
C30H35N3O4 (501.26274300000006)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[2-(1-piperidinyl)ethylamino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-phenylurea
C30H35N3O4 (501.26274300000006)
1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-phenylurea
C30H35N3O4 (501.26274300000006)
1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-phenylurea
C30H35N3O4 (501.26274300000006)
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
C25H44NO7P (501.28552440000004)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] butanoate
C25H44NO7P (501.28552440000004)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] acetate
C25H44NO7P (501.28552440000004)
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (7E,10E,13E,16E)-icosa-7,10,13,16-tetraenoate
C25H44NO7P (501.28552440000004)
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate
C25H44NO7P (501.28552440000004)
1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine
C25H44NO7P (501.28552440000004)
2-arachidonyl-sn-glycero-3-phosphoethanolamine
C25H44NO7P (501.28552440000004)
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (5Z,8Z,11Z,14Z)-eicosatetraenoyl (arachidonoyl).
lysophosphatidylethanolamine (20:4(8Z,11Z,14Z,17Z)/0:0)
C25H44NO7P (501.28552440000004)
A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 8Z,11Z,14Z,17Z-eicosapentaenoyl (omega-3-arachidonoyl).
icas#21
A 4-O-(1H-indol-3-ylcarbonyl)ascaroside derived from (2E,12R)-12-hydroxytridec-2-enoic acid. It is a metabolite of the nematode Caenorhabditis elegans.
lysophosphatidylethanolamine 20:4
C25H44NO7P (501.28552440000004)
An acyl-sn-glycero-3-phosphoethanolamine in which the acyl group contains twenty carbons and four double bonds. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphoethanolamine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphoethanolamine.
Lysophosphatidylethanolamine(20:4/0:0)
C25H44NO7P (501.28552440000004)
A lysophosphatidylethanolamine 20:4 in which the acyl group is located at position 1.
lysophosphatidylethanolamine 0:0/20:4(8Z,11Z,14Z,17Z)
C25H44NO7P (501.28552440000004)
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 8Z,11Z,14Z,17Z-eicosapentaenoyl (omega-3-arachidonoyl).
1-Arachidonoyl-sn-glycero-3-phosphoethanolamine
C25H44NO7P (501.28552440000004)
A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as arachidonoyl.
2-arachidonoyl-sn-glycero-3-phosphoethanolamine zwitterion
C25H44NO7P (501.28552440000004)
A 2-acyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of 2-arachidonoyl-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.
PE(20:4)
C25H44NO7P (501.28552440000004)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LdMePE(18:4)
C25H44NO7P (501.28552440000004)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
1,4,7,10-tetrahydroxy-3-[(4-hydroxyphenyl)methyl]-9-methyl-6-(2-methylpropyl)-3h,6h,9h,12h,15h,16h,17h,17ah-pyrrolo[1,2-a]1,4,7,10,13-pentaazacyclopentadecan-13-one
C25H35N5O6 (501.25872100000004)
21,23-dihydroxy-4,6,8,10,12-pentamethyl-15-oxa-22-azaheptacyclo[12.9.3.2¹⁶,¹⁹.1¹,²¹.0⁴,²⁵.0⁷,²⁶.0⁸,¹³]nonacosa-2,5,16,18,22,28-hexaen-24-one
C32H39NO4 (501.28789340000003)
(1s,4r,5s,16s,19s,23r)-19-hydroxy-4,5,24,24-tetramethyl-11-(3-methylbut-2-en-1-yl)-25,26-dioxa-7-azaheptacyclo[21.2.1.0¹,²⁰.0⁴,¹⁹.0⁵,¹⁶.0⁶,¹⁴.0⁸,¹³]hexacosa-6(14),8,10,12,20-pentaen-22-one
C32H39NO4 (501.28789340000003)